280 related articles for article (PubMed ID: 26067584)
1. Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain.
La Porta C; Bura SA; Llorente-Onaindia J; Pastor A; Navarrete F; García-Gutiérrez MS; De la Torre R; Manzanares J; Monfort J; Maldonado R
Pain; 2015 Oct; 156(10):2001-2012. PubMed ID: 26067584
[TBL] [Abstract][Full Text] [Related]
2. CB
Saravia R; Flores Á; Plaza-Zabala A; Busquets-Garcia A; Pastor A; de la Torre R; Di Marzo V; Marsicano G; Ozaita A; Maldonado R; Berrendero F
Biol Psychiatry; 2017 Apr; 81(7):625-634. PubMed ID: 27737762
[TBL] [Abstract][Full Text] [Related]
3. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain.
Sagar DR; Staniaszek LE; Okine BN; Woodhams S; Norris LM; Pearson RG; Garle MJ; Alexander SP; Bennett AJ; Barrett DA; Kendall DA; Scammell BE; Chapman V
Arthritis Rheum; 2010 Dec; 62(12):3666-76. PubMed ID: 20722027
[TBL] [Abstract][Full Text] [Related]
4. An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.
Hutch CR; Hillard CJ; Jia C; Hegg CC
Neuroscience; 2015 Aug; 300():539-53. PubMed ID: 26037800
[TBL] [Abstract][Full Text] [Related]
5. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
6. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
[TBL] [Abstract][Full Text] [Related]
7. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC
Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
Köfalvi A; Lemos C; Martín-Moreno AM; Pinheiro BS; García-García L; Pozo MA; Valério-Fernandes Â; Beleza RO; Agostinho P; Rodrigues RJ; Pasquaré SJ; Cunha RA; de Ceballos ML
Neuropharmacology; 2016 Nov; 110(Pt A):519-529. PubMed ID: 26976670
[TBL] [Abstract][Full Text] [Related]
9. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
10. Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system.
Martín-Sánchez A; Warnault V; Montagud-Romero S; Pastor A; Mondragón N; De La Torre R; Valverde O
Pharmacol Biochem Behav; 2019 Aug; 183():22-31. PubMed ID: 31220547
[TBL] [Abstract][Full Text] [Related]
11. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
Richardson D; Pearson RG; Kurian N; Latif ML; Garle MJ; Barrett DA; Kendall DA; Scammell BE; Reeve AJ; Chapman V
Arthritis Res Ther; 2008; 10(2):R43. PubMed ID: 18416822
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons.
Stumpf A; Parthier D; Sammons RP; Stempel AV; Breustedt J; Rost BR; Schmitz D
Neuropharmacology; 2018 Sep; 139():217-225. PubMed ID: 30025920
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
15. Opposing roles of CB
Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
[TBL] [Abstract][Full Text] [Related]
16. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.
Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M
J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
18. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
[TBL] [Abstract][Full Text] [Related]
19. Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.
Basavarajappa BS; Nagre NN; Xie S; Subbanna S
Hippocampus; 2014 Jul; 24(7):808-18. PubMed ID: 24648181
[TBL] [Abstract][Full Text] [Related]
20. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
